__NUXT_JSONP__("/drugs/Upamostat", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1191101-18-4",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable, 3-amidinophenylalanine-derived, second generation serine protease inhibitor prodrug targeting the human urokinase plasminogen activator (uPA) system with potential antineoplastic and antimetastatic activities. After oral administration, upamostat is converted to the active N alpha-(2,4,6-triisopropylphenylsulfonyl)-3-amidino-(L)-phenylalanine-4-ethoxycarbonylpiperazide (WX-UK1), which inhibits several serine proteases, particularly uPA; inhibition of uPA may result in the inhibition of tumor growth and metastasis. uPA is a serine protease involved in degradation of the extracellular matrix and tumor cell migration and proliferation.",fdaUniiCode:"S5M7KW6U17",identifier:"C73985",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C783"],synonyms:["1-Piperazinecarboxylic Acid, 4-((2S)-3-(3-((E)-Amino(hydroxyimino)methyl)phenyl)-1-oxo-2-(((2,4,6-tris(1-methylethyl)phenyl)sulfonyl)amino)propyl)-, Ethyl Ester","UPAMOSTAT",a,"WX-671"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FUpamostat",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Upamostat","","2021-10-30T13:44:09.823Z")));